<DOC>
	<DOCNO>NCT00782951</DOCNO>
	<brief_summary>Patients receive single intravenous ( IV ) infusion administer 3 minute either ORG 28611 ( SCH 900111 ) , 0.12 mg/kg morphine sulphate , placebo , within 6 hour dental surgery , experience moderate severe dental pain . Patient evaluate pain assessment Baseline , 5 , 10 , 15 , 30 , 45 , 60 , 90 minute ; 2 8 hour rescue medication need .</brief_summary>
	<brief_title>A Comparison Analgesic Efficacy Between Single Dose ORG 28611 , Morphine , Placebo After Dental Impaction Surgery ( Study P05800 )</brief_title>
	<detailed_description />
	<mesh_term>Tooth , Impacted</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Has least one mandibular partial full bony impact third molar require extraction . An ipsilateral maxillary third molar may also extract may adjacent supernumerary tooth ( teeth ) Is willing able understand complete pain evaluation Is male age 18 40 year ( inclusive ) A subject , sexual partner childbearing potential , agree use barrier contraception addition partner use another method three month time dose . Also agree abstain sexual intercourse pregnant lactate woman use condom . Has body mass index ( BMI ) less equal 32 kg/m^2 body weight least 65 kg Is generally good health Is able speak , read , understand English provide meaningful write informed consent Is able remain research center entire 24hours trial period Has initial pain intensity score least 45mm 100mm VAS moderate severe pain 4point categorical scale within 6 hour end surgery ( VAS primary parameter categorical secondary parameter ) Is willing return research center posttreatment visit 5 9 day surgery complete day 30 SAE telephone call . Has uncontrolled clinically significant cardiovascular , respiratory , gastrointestinal , renal , hepatic , metabolic , hematological , immunological disease Has history seizure , family history seizure disorder , psychotic illness Has know allergy significant adverse reaction opioids opioid antagonist , paracetamol ibuprofen Has history chronic opioid cannabis use abuse within 6 month prior start trial Has positive urine drug test screen prior surgery Has participate trial investigational drug device within 30 day prior trial Has take follow drug within 4 hour 5 elimination halflives ( whichever great ) prior dose : aspirin , acetaminophen ( paracetamol ) , nonsteroidal antiinflammatory drug ( NSAIDs , COX2 inhibitor ) , opioids , opioid combination drug , sedativehypnotics , muscle relaxant , and/or sedate antihistamine Has take longacting analgesic ( e.g. , naproxen celecoxib ) central nervous system ( CNS ) depressant within 12 hour prior dose Has take monoamine oxidase ( MAO ) inhibitor tricyclic antidepressant drug within 4 week prior administration trial medication Has take selective serotonin norepinephrine reuptake inhibitor ( SSRI SNRI ) within 4 week prior start trial Has medical psychiatric condition compromise patient 's ability give inform consent appropriately complete pain assessment . Has abnormal clinically significant EEG and/or EEG indicate possible seizure ( like ) disorder accord follow abnormality ( without clinical significance ) : spike wave activity ( epileptiform activity ) paroxysmal activity abnormal slow abnormal beta activity asymmetry rightleft anteriorposterior within normal limit screen Has alcohol caffeine form 24 hour surgery Has abnormal laboratory result screen opinion investigator exclusionary .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>